Pricing Log in Create free account

Inovio Pharmaceuticals, Inc. (INO) vs PepGen, Inc. (PEPG)

Inovio Pharmaceuticals, Inc. and PepGen, Inc. are both Biotechnology companies. Inovio Pharmaceuticals, Inc. and PepGen, Inc. are of similar size ($169.7M and $167.5M). Across the 10 metrics below, PepGen, Inc. leads on 6 and Inovio Pharmaceuticals, Inc. on 4.

Valuation

Metric INO PEPG Biotechnology median
P/E n/m n/m 10.26
P/S 310.99 n/m 9.18
P/B 27.45 1.34 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales 259.00 n/m 8.98
Earnings yield (78.57%) (56.71%) (34.89%)
Free cash flow yield (66.73%) (43.48%) (24.52%)

Profitability

Metric INO PEPG Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (409.87%) (75.45%) (50.12%)
Return on assets (114.64%) (59.06%) (45.60%)
Return on invested capital 0.00% (2,076.25%) 0.00%

Growth

Metric INO PEPG Biotechnology median
Revenue growth (TTM) (54.82%) — 6.26%
EPS growth (last fiscal year) 54.18% 25.61% 29.88%
Revenue growth, 5-year CAGR (61.18%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric INO PEPG Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.00 13.36 4.89
Net debt to EBITDA 0.70 1.64 1.01

Dividend

Metric INO PEPG Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric INO PEPG Biotechnology median
Market cap 167.50m 169.69m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack